Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 1285 Specimen Handling 928 Carboplatin 837 Magnetic Resonance Spectroscopy 834 Cyclophosphamide 808 Cisplatin 736 Nivolumab 681 Paclitaxel 635 Radiotherapy 618 Gemcitabine 580 Biopsy 560 Bevacizumab 486 Dexamethasone 444 fludarabine 410 Docetaxel 385 venetoclax 372 Oxaliplatin 367 Capecitabine 363 Fluorouracil 358 atezolizumab 353 durvalumab 340 Rituximab 336 Drug Therapy 334 Radiosurgery 321 Doxorubicin 320 Blood Specimen Collection 317 Standard of Care 311 Pemetrexed 308 Ipilimumab 303 Radiation 289

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

darlin protein, Dictyostelium × 1 year × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡